Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» There's a Silver Lining in Pfizer's Dark Cloud
There's a Silver Lining in Pfizer's Dark Cloud
There's a Silver Lining in Pfizer's Dark Cloud
Submitted by
admin
on November 3, 2023 - 10:56am
Source:
Motley Fool
News Tags:
Pfizer
earnings
Eliquis
Ibrance
patents
Headline:
There's a Silver Lining in Pfizer's Dark Cloud
snippet:
Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its forecasts for coronavirus product sales.
The company also faces potential sales declines in other blockbusters as they lose exclusivity.
But Pfizer is progressing on a plan to boost growth.
Do Not Allow Advertisers to Use My Personal information